Journal for ImmunoTherapy of Cancer (Oct 2021)

Correction: Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection

DOI
https://doi.org/10.1136/jitc-2020-001225corr1
Journal volume & issue
Vol. 9, no. 10

Abstract

Read online

No abstracts available.